» Articles » PMID: 11164377

[(3)H]ZM241385--an Antagonist Radioligand for Adenosine A(2A) Receptors in Rat Brain

Overview
Journal Eur J Pharmacol
Specialty Pharmacology
Date 2001 Feb 13
PMID 11164377
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Binding of the novel adenosine A(2A) receptor-selective antagonist radioligand [2-(3)H]-4-(2-[7-amino-2-(2-furyl)(1,2,4)triazolo(2,3-a)(1,3,5,)triazin-5-yl amino]ethyl)phenol ([(3)H]ZM241385) was examined using particulate preparations and frozen sections of rat brain. In membranes from the rat striatum, binding was saturable, reversible and temperature-dependent. Analysis of saturation isotherms indicated that [(3)H]ZM241385 bound with high affinity (K(d) of 0.84 nM), high density (1680 fmol mg protein(-1)) and with a high proportion of specific binding (93% at 1 nM radioligand). Examination of competition profiles indicated that [(3)H]ZM241385 bound to sites with an A(2A) adenosine receptor-like rank order. The presence of guanosine 5'-(3-thio)-triphosphate failed to alter either [(3)H]ZM241385 binding or agonist competition for [(3)H]ZM241385 binding. Autoradiographic analysis of [(3)H]ZM241385 binding to frozen sections of rat brain indicated specific binding to the rat striatum of similar affinity (K(d) of 0.43 nM) and susceptibility to adenosine receptor ligands. At 2 nM [(3)H]ZM241385, specific binding comprised 95+/-1% total binding. In the hippocampus and frontal cortex, binding of [(3)H]ZM241385 failed to saturate and was of lower density. Taken together, these results indicate that [(3)H]ZM241385 should prove to be a useful radioligand in the characterisation of adenosine A(2A) receptors.

Citing Articles

Allosteric Interactions between Adenosine A and Dopamine D Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics, and Opportunities for PET Imaging.

Prasad K, de Vries E, Elsinga P, Dierckx R, van Waarde A Int J Mol Sci. 2021; 22(4).

PMID: 33572077 PMC: 7915359. DOI: 10.3390/ijms22041719.


Molecular probes for the human adenosine receptors.

Yang X, Heitman L, IJzerman A, van der Es D Purinergic Signal. 2020; 17(1):85-108.

PMID: 33313997 PMC: 7954947. DOI: 10.1007/s11302-020-09753-8.


Mass spectrometry-based ligand binding assays on adenosine A1 and A2A receptors.

Massink A, Holzheimer M, Holscher A, Louvel J, Guo D, Spijksma G Purinergic Signal. 2015; 11(4):581-94.

PMID: 26482925 PMC: 4648803. DOI: 10.1007/s11302-015-9477-0.


Structural and energetic effects of A2A adenosine receptor mutations on agonist and antagonist binding.

Keranen H, Gutierrez-de-Teran H, Aqvist J PLoS One. 2014; 9(10):e108492.

PMID: 25285959 PMC: 4186821. DOI: 10.1371/journal.pone.0108492.


The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Alexander S, Benson H, Faccenda E, Pawson A, Sharman J, Spedding M Br J Pharmacol. 2014; 170(8):1459-581.

PMID: 24517644 PMC: 3892287. DOI: 10.1111/bph.12445.